StarTric develops a transcatheter tricuspid valve repair system to treat tricuspid heart valves.
StarTric has raised $8.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
StarTric's investors include NLC, EIC Accelerator, Growth Engine.
StarTric is headquartered in Milan, Italy.
StarTric develops a transcatheter tricuspid valve repair system to treat tricuspid heart valves.
StarTric is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StarTric — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/startric. Accessed July 21, 2026.
VCBacked. (2025). StarTric — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/startric
{{cite web |title=StarTric — Funding & Investors |url=https://www.vcbacked.co/company/startric |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated